Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
HERVs in neuropathogenesis.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
Comparing individual and group intervention for psychological adjustment in people with multiple sclerosis: A feasibility randomised controlled trial.
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Human Aquaporin 4281-300 Is the Immunodominant Linear Determinant in the Context of HLA-DRB1*03:01: Relevance for Diagnosing and Monitoring Patients With Neuromyelitis OpticaImmunodominant Linear Determinants of hAQP4.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
FTY720 attenuates excitotoxicity and neuroinflammation.
Effect of virtual reality-based balance training in multiple sclerosis.
The toxicology of HMG-CoA reductase inhibitors: prediction of human risk.
B-cell-directed therapy: which B cells should be targeted and how?
Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996-2008.
Scoring treatment response in patients with relapsing multiple sclerosis.
Atomic view of a toxic amyloid small oligomer.
Unilateral ankle dorsiflexor spasticity: an uncommon, disabling complication of transverse myelitis.
Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
[Progress of demyelinating animal models in the central nervous system].
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Pages
« first
‹ previous
…
245
246
247
248
249
250
251
252
253
…
next ›
last »